Aurolife Pharma recalls

Aurolife Pharma has 14 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 28 Jun 2023. 1 is still ongoing. The most frequent reason is potency & assay.

Total recalls14since 2019

Last 12 months0reported

Class I00% of total

Ongoing1latest 28 Jun 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 13 93%Class III 1 7%

Why aurolife pharma is recalled

Potency & Assay1393%
Foreign Material17%

Product types

Allergy Medication1179%

By year

202317%
2022214%
20191179%

Ongoing aurolife pharma recalls

1 active

Reported	Class	Recall	Company	Reason	Where
28 Dec 2022Drug	CLASS II	Glycopyrrolate Tablets, USP, 1 mg recalled by Aurolife PharmaGlycopyrrolate	Aurolife Pharma	Potency & Assay	Nationwide

All aurolife pharma recalls, newest first

14 total

Reported	Class	Recall	Company	Reason	Where
28 Jun 2023Drug	CLASS III	Glycopyrrolate Tablets, USP, 1 mg recalled by Aurolife PharmaGlycopyrrolate	Aurolife Pharma	Potency & Assay	Nationwide
28 Dec 2022Drug	CLASS II	Glycopyrrolate Tablets, USP, 1 mg recalled by Aurolife PharmaGlycopyrrolate	Aurolife Pharma	Potency & Assay	Nationwide
6 Apr 2022Drug	CLASS II	Glycopyrrolate Tablets, USP, 1 mg recalled by Aurolife PharmaGlycopyrrolate	Aurolife Pharma	Foreign Material	Nationwide
25 Sep 2019Drug	CLASS II	Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, equate recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Fexofenadine Hydrochrloride Tablets USP, 180 mg recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Fexofenadine Hydrochloride Tablets USP, 180 mg recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Allergy Relief (fexofenadine hydrochrloride) tablets recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Fexofenadine HCL Tablets USP, 180 mg, 500's Brite Stock recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	fexofenadine hydrochloride tablets USP, 180 mg, Member's Mark recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg recalled	Aurolife Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Fexofenadine Hydrochloride Tablets USP, 180 mg recalled	Aurolife Pharma	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.